“USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS”. 2010. Mediterranean Journal of Hematology and Infectious Diseases 2 (1): e2010003. https://doi.org/10.4084/mjhid.2010.003.